Anti-Radiation Drug Sales Skyrocket After Trump Compares "Nuclear Button” Size

According to NBC Health's Troy Jones, who operates the website Nukepills, the demand for potassium iodide  jumped last week after President Trump tweeted that he had a “much bigger & more powerful” nuclear button than North Korean Leader Kim Jong Un.


“On Jan. 2, I basically got in a month’s supply of potassium iodide and I sold out in 48 hours,” said Jones, 53, who is a domestic and international distributor of emergency radiation products.

In the 48-hour period from Trump’s “nuclear button” tweet, Jones shipped about 140,000 doses of potassium iodide, which blocks the thyroid from absorbing radiation and ultimately help thwart cancer in a nuclear event. Jones further said a typical week of shipments without President Trump stoking atomic war runs about 8,400 doses to private individuals. In other words, Trump increased Jones' sales by over 16x last week. Jones notes the sales figures do not include government agencies, hospitals, and universities.

To confirm this trend, Alan Morris, president of the Virginia-based pharmaceutical firm Anbex Inc, which specializes in radiation protection, said he’d seen an increase in demand, too.

We are a wonderful barometer of the level of anxiety in the country,” said Morris.

Morris appears to be right: the search term “nuclear war” and “trump nuclear war” have surged since Trump entered office.

asd

 

asd

Jones warns that the escalating war of words between the U.S. and North Korea has contributed to widespread fear across the country. Although Jones says some of his buyers are “preppers,” many new buyers today are regular families seeking protection from nuclear war.

Such concerns were on displayed last week, when the Centers for Disease Control and Prevention (CDC) announced that it would conduct an unprecedented briefing on January 16 concerning the “public health response to a nuclear detonation” over the skies of the United States.


< Prev 1 2 Next >

Sign Up

Get the InvestingChannel
Free e-Letter Today

Learn More

Independent market opinion, analysis and ideas - delivered every business day

Premium market opinions, analysis, and ideas - delivered every business day

Editor's Picks